Phase I Study of HRS-1635 in B-cell Malignancies
Phase I Study of HRS-1635 in B-cell Malignancies
Recruiting · NCT07583212 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of HRS-1635 in B-cell Malignancies | B-cell Malignancy | Recruiting | Phase 1 | 2026-07-13 | NCT07583212 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chengdu Suncadia Medicine Co., Ltd. | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sichuan Cancer Hospital | Chengdu | China | 46 |